US 7635683
Quinoxalinyl tripeptide hepatitis C virus inhibitors
granted A61KA61K38/00
Quick answer
US patent 7635683 (Quinoxalinyl tripeptide hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00